Menopause and Gut Health: A Clinical Link Through Hormones, Inflammation, and the Microbiome
Emerging clinical research has identified a significant relationship between menopause and gut health, suggesting that hormonal changes during midlife may alter the intestinal microbiome and contribute to a range of physical symptoms and long-term health risks. Menopause is characterized by the permanent cessation of menstruation due to declining ovarian function, particularly reductions in oestrogen and progesterone. These hormonal shifts affect multiple body systems, including the gastrointestinal tract, where they can influence microbial diversity, gut permeability, immune function, and metabolic health.
The collection of microorganisms inhabiting the gastrointestinal tract, known as the gut microbiota, plays an essential role in digestion, nutrient absorption, immune regulation, and hormone metabolism. Within this ecosystem exists a subgroup of bacteria called the estrobolome, which consists of microbes capable of metabolising and regulating circulating oestrogen levels. Certain intestinal bacteria produce enzymes known as β-glucuronidases, which help reactivate oestrogens in the gut, allowing them to be reabsorbed into circulation. Research suggests that alterations in gut microbial composition can therefore influence systemic hormone levels.
As women enter menopause, falling oestrogen concentrations appear to correspond with changes in microbial diversity. Clinical studies have shown that postmenopausal women often display a reduction in beneficial bacteria and an increase in microbial patterns resembling those seen in men of similar age. A study published in Nature Communications observed that lower oestrogen states were associated with altered gut microbiome profiles and reduced bacterial richness. Reduced diversity is significant because a diverse microbiome is generally linked with stronger immune resilience and metabolic health.
One clinically important mechanism involves intestinal permeability, commonly referred to as “leaky gut.” Oestrogen helps maintain the integrity of tight junction proteins that regulate the gut barrier. During menopause, lower oestrogen levels may weaken this barrier, allowing bacterial fragments and inflammatory molecules such as lipopolysaccharides (LPS) to enter systemic circulation. This process may contribute to chronic low-grade inflammation, often termed inflammaging, which has been linked to many menopause-associated conditions including weight gain, insulin resistance, fatigue, and cardiovascular disease.
Clinical evidence also suggests a relationship between menopausal changes in gut health and metabolic dysfunction. Weight gain and central adiposity commonly occur during menopause, partly due to hormonal changes but potentially also because of microbiome alterations. Studies have demonstrated that shifts in gut bacteria may affect energy extraction from food and influence insulin sensitivity. A 2022 review in Frontiers in Endocrinology proposed that menopause-associated dysbiosis may contribute to obesity and metabolic syndrome through inflammatory and endocrine pathways.
Bone health may also be affected. Declining oestrogen levels are strongly associated with osteoporosis, yet emerging research indicates the gut microbiome may influence calcium absorption and bone metabolism. Animal and early human studies suggest that beneficial microbes may regulate inflammatory mediators involved in bone turnover, highlighting another pathway linking gut health and menopausal outcomes.
Collectively, current clinical evidence indicates that menopause is not solely a reproductive transition but also a period of substantial gastrointestinal and microbial change. Understanding the interaction between hormones and the microbiome may create future opportunities for targeted therapies involving diet, probiotics, and microbiota-focused interventions to improve health during menopause.
https://maxilinreview.com/fingersjones
